Investor Communications

Amgen to Brief Investors on Oncology Portfolio at ESMO 2026

Amgen to Brief Investors on Oncology Portfolio at ESMO 2026

Thousand Oaks – October 21, 2026 -- Amgen (NASDAQ:AMGN) will hold an investor webcast on Saturday, October 21, 2026, at 11:30 a.m. PT to discuss its oncology portfolio and selected data presented at the European Society of Medical Oncology Congress (ESMO) 2026.

Two senior executives lead Amgen's ESMO 2026 investor call

Murdo Gordon, executive vice president of Global Markets and Policy, and Jean-Charles Soria, senior vice president of oncology within Global Development, will lead the session. Other members of Amgen's management team will also take part.

Webcast is open to media, investors and the public

The event will be broadcast live over the internet and is open to members of the news media, investors and the general public. Presentation times, webcast availability and links are listed on Amgen's Investor Relations Events Calendar.

Elanco Executives to Address Investors at Morgan Stanley Healthcare Conference

Elanco Executives to Address Investors at Morgan Stanley Healthcare Conference

Indianapolis – September 16, 2026 -- Elanco Animal Health Incorporated (NYSE: ELAN) confirmed its leadership team will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026.

Top executives to field investor questions in fireside chat format

CEO Jeff Simmons, CFO Bob VanHimbergen, and Bobby Modi, executive vice president for U.S. Pet Health and Global Digital Transformation, will join a fireside chat session scheduled for 2:35 p.m. ET on September 15.

Digital transformation leadership signals strategic pivot in pet health segment

Modi's dual role overseeing both U.S. Pet Health operations and Global Digital Transformation places technology investment discussions on the agenda alongside core business performance.